日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Cancer-associated fibroblasts induce sorafenib resistance of hepatocellular carcinoma cells through CXCL12/FOLR1

更正:癌症相关成纤维细胞通过 CXCL12/FOLR1 诱导肝细胞癌细胞对索拉非尼产生耐药性

Zhao, Jiali; Lin, En; Bai, Zirui; Jia, Yingbin; Wang, Bo; Dai, Yihua; Zhuo, Wenfeng; Zeng, Guifang; Liu, Xialei; Cai, Chaonong; Li, Peiping; Zou, Baojia; Li, Jian

CHAF1B: the hidden culprit behind sorafenib resistance in hepatocellular carcinoma

CHAF1B:肝细胞癌索拉非尼耐药背后的隐藏罪魁祸首

Zhuo, Wenfeng; Zhao, Jiali; Zheng, Zhouying; Cai, Shanglin; Zeng, Guifang; Lin, En; Bai, Zirui; Wang, Bo; Jia, Yingbin; Li, Peiping; Li, Jian

CAT and CXCL8 are crucial cofactors for the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma, the immune infiltration and prognosis of hepatocellular carcinoma.

CAT 和 CXCL8 是非酒精性脂肪性肝炎发展为肝细胞癌的关键辅助因子,也是肝细胞癌免疫浸润和预后的关键辅助因子

Yang Liang, Li Peiping, Zhao JiaLi, Bai Zirui, Zeng Guifang, Liu Xialei, Zou Baojia, Li Jian